Every Form 4 that National Healthcare Corp. (NHC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHC filings page.
National Healthcare Corp senior executive receives stock option grant. Sr. VP Patient Services Vicki L. Dodson was granted options to purchase 14,000 shares of National Healthcare Corp common stock on February 23, 2026, at an exercise price of $0.00 per share under the 2020 Omnibus Equity Incentive Plan.
According to the grant’s terms, these stock options vest in three equal installments: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. Following the grant, she directly holds multiple option positions and 10,289.5455 shares of common stock in her name.
National Healthcare Corp CEO and director Stephen Fowler Flatt received a grant of 20,000 options to purchase common stock on February 23, 2026 under the 2020 Omnibus Equity Incentive Plan. The options have a stated exercise price of $0.00 per share in the filing.
These stock options vest and become exercisable in three equal installments: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. After this grant, Flatt directly holds 20,000 of these options, alongside separately reported existing option and common stock holdings.
National Healthcare Corp SVP and CFO Brian F. Kidd received a grant of 14,000 options to purchase common stock on February 23, 2026. The options were granted at an exercise price of $0.00 under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
The options vest ratably over three years, with one-third vesting on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. As of this grant, Kidd also directly held other option positions and 23,717 shares of common stock.
FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr reported an equity award of stock options. On February 23, 2026, he received options to purchase 14,000 shares of common stock under the 2020 Omnibus Equity Incentive Plan.
These options vest in three equal installments: one‑third on February 23, 2027, one‑third on February 23, 2028, and the final one‑third on February 23, 2029. The award is structured as long‑term incentive compensation rather than an open‑market share purchase.
NATIONAL HEALTHCARE CORP reported that Sr. VP of Operations Timothy J. Shelly received a grant of stock options to purchase 14,000 shares of common stock on February 23, 2026. The options were granted at an exercise price reported as $0.0000 per share.
The options were issued under the company’s 2020 Omnibus Equity Incentive Plan and will vest ratably over three years. One-third will vest on February 23, 2027, another one-third on February 23, 2028, and the final one-third on February 23, 2029, after which they become exercisable.
National Healthcare Corp (NHC) director James Paul Abernathy reported an option exercise and related share withholding. On January 15, 2026, he exercised an option granted in 2022 for 7,500 shares of common stock at a price of $69.82 per share. The company withheld 3,732 shares at $139.01 per share to pay the exercise price, resulting in net additional shares held.
Following these transactions, Abernathy beneficially owns 40,162 shares of NHC common stock, held directly. The exercised options were granted under the company’s 2020 Omnibus Equity Incentive Plan and are noted as exempt from certain short-swing profit rules. He also continues to hold option grants from 2023, 2024 and 2025, each covering 7,500 shares of common stock.
National Healthcare Corp Senior VP & General Counsel reported an equity transaction involving company stock. On 1/1/2026, a total of 1,162 shares of restricted stock that were originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. To cover tax obligations from this vesting, the company withheld 496 shares, recorded as a disposition at a price of $137.9 per share under transaction code F.
After this tax withholding, the insider directly beneficially owns 9,942 shares of National Healthcare Corp common stock. The filing also lists outstanding stock options giving rights to purchase additional shares in the future, all held directly by the reporting person.
National Healthcare Corp (NHC) insider equity update: A Form 4 reports that President & COO Michael Ussery had 2,063 shares of common stock withheld on 12/31/2025, coded as an "F" transaction. This reflects shares surrendered to cover tax obligations related to vesting equity awards, rather than an open-market sale. The shares were valued at $137.09 each for this tax withholding transaction, and following it, Ussery beneficially owned 158,460 shares of NHC common stock. An accompanying note explains that on 1/1/2026, a total of 4,835 restricted shares granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested, with the 2,063 shares withheld by the company to satisfy tax requirements.
National Healthcare Corp executive reports share withholding for taxes and updates equity awards. A Senior VP & CIO of NATIONAL HEALTHCARE CORP (NHC) reported a Form 4 transaction dated 01/01/2026. On that date, 33 1/3% (1,070 shares) of previously granted restricted stock vested from awards originally granted on 3/8/2023, 3/5/2024, and 3/5/2025. The company withheld 403 shares, coded as an "F" transaction, at a price of $137.09 per share to cover tax obligations. Following this transaction, the officer beneficially owned 14,117.0547 shares of common stock held directly.
The filing also lists outstanding stock options held directly by the officer. These include an option to purchase 7,467 shares of common stock at $53.94 per share expiring 03/08/2028, an option to purchase 12,000 shares at $94.10 per share expiring 03/05/2029, and an option to purchase 13,500 shares at $90.62 per share expiring 02/24/2030.
National HealthCare Corp reported an insider equity update for Sr. VP Patient Services Vicki L. Dodson. On 01/01/2026, a total of 846 shares of restricted stock granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. To cover related tax obligations, the company withheld 319 shares at a price of $137.09 per share, coded as an "F" transaction (tax withholding) on the form. Following this transaction, Dodson directly beneficially owns 10,289.5455 shares of NHC common stock. She also holds stock options to purchase 3,734, 8,000, and 13,500 shares of common stock at exercise prices of $53.94, $94.10, and $90.62, expiring in 2028, 2029, and 2030, respectively.
National Healthcare Corp senior vice president and CFO reported routine equity activity. On 01/01/2026, 33 1/3% (or 1,185 shares) of previously granted restricted stock vested, and the company withheld 447 shares of common stock at $137.09 per share to cover tax obligations. Following this transaction, the officer beneficially owned 23,693 shares of common stock directly.
The filing also shows stock options held by the officer. These include options to purchase 8,000 shares of common stock at an exercise price of $53.94 exercisable from 03/08/2024 until 03/08/2028, options on another 8,000 shares at $94.10 exercisable from 03/05/2025 until 03/05/2029, and options on 13,500 shares at $90.62 exercisable from 02/24/2026 until 02/24/2030, all held directly.
National Healthcare CorpJanuary 1, 2026, 2,400 shares of restricted stock that were originally granted on March 8, 2023, March 5, 2024, and March 5, 2025 vested. To cover tax obligations, the company withheld 1,024 shares at a price of $137.09 per share, a transaction reported with code "F" for tax withholding.
After this transaction, Flatt beneficially owned 59,147 shares of common stock directly. He also holds stock options covering 6,147 shares at $53.94 exercisable until March 8, 2028, 10,000 shares at $94.10 exercisable until March 5, 2029, and 18,000 shares at $90.62 exercisable until February 28, 2030, all reported as directly owned derivative securities.
National Healthcare Corp. insider transaction: A Form 4 reports that CEO and director Stephen Flatt disposed of 450 shares of National Healthcare Corp. common stock on 12/29/2025 in a transaction coded “G” at a reported price of $0, typically indicating a gift. Following this transaction, he beneficially owns 60,171 shares of common stock directly.
The filing also lists stock options held directly by the reporting person: an option to purchase 6,147 shares at an exercise price of $53.94 exercisable from 03/08/2024 and expiring 03/08/2028; an option to purchase 10,000 shares at $94.10 exercisable from 03/05/2025 and expiring 03/05/2029; and an option to purchase 18,000 shares at $90.62 exercisable from 02/28/2026 and expiring 02/28/2030.
National Healthcare Corp (NHC) senior executive reports equity gift. The company’s SVP and CFO filed a report showing a bona fide gift of 350 shares of National Healthcare Corp common stock on 12/23/2025, recorded at a price of $0 per share, leaving 24,140 common shares beneficially owned directly after the transaction.
The filing also lists outstanding stock options held directly by the executive, including options to purchase 8,000 shares at an exercise price of $53.94 expiring on 03/08/2028, options on 8,000 shares at $94.10 expiring on 03/05/2029, and options on 13,500 shares at $90.62 expiring on 02/24/2030.
National Healthcare Corp. officer and Senior Vice President of Operations reported a sale of company stock. On 12/17/2025, the insider sold 2,454 shares of common stock at a price of $139.42 per share, leaving 0 shares of common stock beneficially owned in the non-derivative table. The insider continues to hold stock options, including options exercisable for 2,400 shares at $53.94 expiring on 03/08/2028, 8,000 shares at $94.10 expiring on 03/05/2029, and 11,000 shares at $90.62 expiring on 02/24/2030, all listed as directly owned.
National HealthCare Corp. insider Michael Ussery, the company’s President and COO, reported several gifts of common stock on 12/17/2025. The transactions, coded "G" and priced at $0, involved small blocks of shares, after which he directly beneficially owned 160,523 shares of National HealthCare common stock. He also holds stock options giving him the right to purchase 4,500 shares at $53.94 exercisable from 03/08/2024 and expiring on 03/08/2028, 9,000 shares at $94.10 exercisable from 03/05/2025 and expiring on 03/05/2029, and 15,000 shares at $90.62 exercisable from 02/24/2026 and expiring on 02/24/2030, all held directly.
National Healthcare Corp’s CEO and director Stephen Flatt reported two transactions in the company’s common stock dated 12/12/2025. Each transaction used code “G” and involved the disposition of 217 and 145 shares, respectively, at a reported price of $0 per share. After these moves, he beneficially owned 60,621 shares of National Healthcare common stock in direct ownership.
The report also lists stock options held by Flatt. He beneficially owned options to purchase 6,147 shares at an exercise price of $53.94 per share expiring on 03/08/2028, 10,000 shares at $94.10 per share expiring on 03/05/2029, and 18,000 shares at $90.62 per share expiring on 02/28/2030, all shown as directly owned. Together, these details outline his current equity stake and option-based exposure to National Healthcare.
National HealthCare Corp. (NHC) senior executive reports option exercise and share withholding. On 12/01/2025, the Senior VP & CIO exercised an option to purchase 3,734 shares of common stock at an exercise price of $63.96 per share, adding 3,734 acquired shares. On the same date, 2,385 shares were disposed of through share withholding at $137.29 per share to cover the exercise price and tax obligations. After these transactions, the executive beneficially owned 14,520.0547 shares of NHC common stock directly.
The report also shows remaining stock options, including options to purchase 7,467 shares at $53.94 per share exercisable from 03/08/2024 until 03/08/2028, 12,000 shares at $94.10 per share exercisable from 03/05/2025 until 03/05/2029, and 13,500 shares at $90.62 per share exercisable from 02/24/2026 until 02/24/2030.
National Healthcare Corp reported insider equity activity by its Senior Vice President of Patient Services. On 11/25/2025, the executive exercised options to purchase 4,000 shares of common stock at $94.10 per share (code M), increasing directly held stock. To cover the exercise price and tax withholding, the company withheld 3,140 shares at a value of $137.95 per share (code F). After these transactions, the executive directly owned 10,608.5455 shares of National Healthcare common stock.
The filing also shows outstanding stock options, including rights to acquire 3,734 shares at $53.94 per share exercisable until 03/08/2028, 8,000 derivative securities remaining from a grant at $94.10 per share expiring on 03/05/2029, and options for 13,500 shares at $90.62 per share exercisable starting 02/24/2026 and expiring on 02/24/2030. The options exercised and held were granted under the company’s 2020 Omnibus Equity Incentive Plan and are stated as exempt from Section 16(b) short-swing profit rules under Rule 16b-3(d).
National HealthCare Corp (NHC) filed a Form 4 reporting that director Emil E. Hassan sold 7,500 shares of common stock on 11/25/2025 in an open market transaction coded “S.” The shares were sold at a price of $138.5164 per share.
After this sale, Hassan directly owns 65,595 NHC common shares. He also holds several stock option awards, each covering 7,500 shares of common stock, with exercise prices ranging from $55.75 to $96.03 and expiration dates between 05/05/2026 and 05/07/2030.
National HealthCare Corp (NHC) CEO and director Stephen Flatt reported insider transactions on a Form 4. On 11/21/2025, he sold 1,000 shares of common stock at $130.33 per share, and after this trade he beneficially owned 59,130 shares. On 11/25/2025, he exercised 1,853 stock options at $53.94 per share, increasing his beneficial ownership to 60,983 shares.
The filing also lists his remaining stock options. He holds 6,147 options with a $53.94 exercise price expiring on 03/08/2028, 10,000 options with a $94.10 exercise price expiring on 03/05/2029, and 18,000 options with a $90.62 exercise price expiring on 02/28/2030. The exercised options were granted under the 2020 Omnibus Equity Incentive Plan and are described as exempt from Section 16(b) under Rule 16b-3(d).
National HealthCare Corp. (NHC) President & COO Michael Ussery reported Form 4 transactions on 11/11/2025. He exercised 4,500 stock options at $53.94 and another 4,500 at $94.10. To cover the exercise price and withholding taxes, the company withheld 1,705 shares and 3,720 shares at $132.20.
After these transactions, he directly beneficially owned 161,523 shares. Remaining option holdings include 4,500 options at $53.94 expiring 03/08/2028, 9,000 options at $94.10 expiring 03/05/2029, and 15,000 options at $90.62 expiring 02/24/2030.
National Healthcare Corp. (NHC) reported insider activity by its Sr. VP of Operations on a Form 4. On 11/11/2025, the executive exercised 2,400 stock options with a $63.96 exercise price and another 4,800 stock options with a $53.94 exercise price, all granted under the 2020 Omnibus Equity Incentive Plan and exempt from Section 16(b) under Rule 16b-3(d.
To cover the exercise price and related tax withholding, the company withheld 1,655 shares and 3,091 shares, reported with transaction code “F” at a price of $132.20. After these transactions, the executive continued to hold common stock directly and also retained unexercised options, including 8,000 options at a $94.10 exercise price expiring on 03/05/2029 and 11,000 options at a $90.62 exercise price expiring on 02/24/2030.
National HealthCare Corp. (NHC) — Form 4 insider activity: Senior VP & General Counsel Josh McCreary exercised stock options and adjusted holdings on 11/11/2025. He acquired 4,000 shares of common stock via option exercise at $94.10 (Code M), then had 3,278 shares withheld to cover the exercise price and taxes (Code F) at $132.20. Following these transactions, he beneficially owned 10,438 shares directly.
Post‑transaction, derivative holdings include options with 8,000 remaining from a grant exercisable until 03/05/2029 at $94.10, plus other options of 4,000 at $53.94 (expiring 03/08/2028) and 13,500 at $90.62 (expiring 02/24/2030).
National HealthCare Corp. (NHC) reported an insider transaction by its SVP, CFO. On 11/11/2025, the officer exercised 4,000 stock options at $94.10 per share (Code M). To cover the exercise price and withholding taxes, 3,224 shares were withheld (Code F). Following these transactions, the officer directly owned 24,490 shares of common stock.
Remaining derivative holdings include options with exercise prices of $53.94 (8,000 shares outstanding), $94.10 (8,000 shares remaining from a 12,000 grant), and $90.62 (13,500 shares), with expirations between 2028 and 2030 as disclosed.
National Healthcare Corp. (NHC) CEO and director Stephen Flatt reported insider transactions on 11/11/2025. He exercised 3,000 options at $94.10 per share (code M) and the company withheld 2,480 shares to cover the exercise price and taxes (code F). Following these transactions, he beneficially owns 60,130 common shares.
Outstanding equity awards listed include options expiring on 03/08/2028 at $53.94 (8,000 shares), on 03/05/2029 at $94.10 (10,000 shares after the exercise), and on 02/28/2030 at $90.62 (18,000 shares).
National HealthCare Corp. (NHC) director Emil E. Hassan reported an open-market sale of 5,500 shares of common stock at $133 per share on 11/12/2025. Following the transaction, he beneficially owns 73,095 shares directly.
The filing also lists multiple director option awards of 7,500 shares per grant, including examples with exercise prices of $71.64 and $96.03, with stated exercisable and expiration dates. A note clarifies that an option previously shown as [2024 Grant] was corrected here to [2025 Grant].
Robert G. Adams, a director of National HealthCare Corp (NHC), exercised options and acquired shares on 09/19/2025. He exercised 4,500 options from a 2021 grant at an exercise price of $71.64, resulting in the acquisition of 4,500 shares reported as an acquisition at $71.64 per share.
The filing shows Mr. Adams beneficially owns 13,579 shares following the transaction through a trust and holds indirect interests through a partnership position of 430,341 shares as general partner. The report also lists outstanding options granted in 2022, 2023, 2024 and 2025, each for 7,500 shares, with varying exercise prices and expiration dates.